Ilya M Rachman bought $4,976 of IMMX
CEO and Chairman at Immix Biopharma, Inc.. 746 shares at an average of $6.67, traded Dec 10, 2025, filed Dec 10, 2025.
Score components
- +25RoleCEO
- 0Trade size$5k at market
- -5Relative to holdingsUnder 1% of holdings (0.1%)
- 0Price contextMid range
- +8Cluster2 insiders buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -27.6%, 3m +55.4%, 6m +21.5%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-25-027109, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 10, 2025 | POpen-market purchase Common Stock | +746 | $6.67 | $4,976 | 1,141,683 | Dec 10, 2025 |
Related signals
Other insiders at Immix Biopharma, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | Immix Biopharma, Inc. | Gabriel S Morris CFO | $5,067 770 shares | +0% | |
| 38Weak | Immix Biopharma, Inc. | Gabriel S Morris CFO | $5,122 2,600 shares | +1% | |
| 36Weak | Immix Biopharma, Inc. | Ilya M Rachman CEO and Chairman | $5,050 2,500 shares | +0% | |
| 25Weak | Immix Biopharma, Inc. | Gabriel S Morris CFO | $5,071 2,225 shares | +1% | |
| 28Weak | Immix Biopharma, Inc. | Ilya M Rachman CEO and Chairman | $4,999 2,178 shares | +0% | |
| 28Weak | IMMXbuy Immix Biopharma, Inc. | Jason Hsu director | $104k 47,700 shares | +6% | |
| 31Weak | IMMXbuy Immix Biopharma, Inc. | Jason Hsu director | $267k 56,000 shares | +7% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.